Medcomtech, S.A.

Symbol: MED.MC

EURONEXT

0.69

EUR

Market price today

  • 0.0000

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 8.92M

    MRK Cap

  • 0.00%

    DIV Yield

Medcomtech, S.A. (MED-MC) Stock Price & Analysis

Shares Outstanding

12.92M

Gross Profit Margin

0.67%

Operating Profit Margin

0.01%

Net Profit Margin

-0.03%

Return on Assets

-0.03%

Return on Equity

-0.42%

Return on Capital Employed

0.02%

Company general description and statistics

Sector: Healthcare
Industry: Medical Distribution
CEO:Mr. Juan Sagales Manas
Full-time employees:124
City:Barcelona
Address:Edificio Brasil
IPO:2010-03-25
CIK:

Medcomtech, S.A. distributes products in the areas of orthopedic surgery, traumatology, neurosurgery, and anesthesia worldwide. The company offers orthopedic surgery, trauma, and neurosurgery products for spine, hip-femur-knee, biologics, and upper and lower limbs, as well as biologics and cements. It also provides anesthesia products in the area of airway management. The company was incorporated in 2001 and is based in Barcelona, Spain.

General Outlook

In simple terms, Medcomtech, S.A. has 12.921 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.666% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.012%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.035%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.028% return, is a testament to Medcomtech, S.A.'s adeptness in optimizing resource deployment. Medcomtech, S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.416%. Furthermore, the proficiency of Medcomtech, S.A. in capital utilization is underscored by a remarkable 0.020% return on capital employed.

Stock Prices

Medcomtech, S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.86, while its low point bottomed out at $0.86. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medcomtech, S.A.'s stock market.

Liquidity Ratios

Analyzing MED.MC liquidity ratios reveals its financial health of the firm. The current ratio of 144.07% gauges short-term asset coverage for liabilities. The quick ratio (7.52%) assesses immediate liquidity, while the cash ratio (7.26%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio144.07%
Quick Ratio7.52%
Cash Ratio7.26%

Profitability Ratios

MED.MC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -3.91% underscores its earnings before tax deductions. The effective tax rate stands at 11.05%, revealing its tax efficiency. The net income per EBT, 88.95%, and the EBT per EBIT, -315.79%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.24%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-3.91%
Effective Tax Rate11.05%
Net Income per EBT88.95%
EBT per EBIT-315.79%
EBIT per Revenue1.24%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.44, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding8
Days of Inventory Outstanding361
Operating Cycle361.04
Days of Payables Outstanding432
Cash Conversion Cycle-71
Payables Turnover0.84
Inventory Turnover1.01
Fixed Asset Turnover5.75
Asset Turnover0.81

Cash Flow Ratios

Lastly, the operating cash flow sales ratio, -0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow Sales Ratio-0.09
Free Cash Flow to Operating Cash Flow Ratio1.63
Cash Flow Coverage Ratio-0.38
Short Term Coverage Ratio-1.83
Capital Expenditure Coverage Ratio-1.58
Dividend Paid and Capex Coverage Ratio-1.58

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.53%, highlights its total liabilities relative to assets. With a debt-equity ratio of 5.05, we discern the balance between debt and equity financing. The long-term debt to capitalization, 79.95%, and total debt to capitalization, 83.48%, ratios shed light on its capital structure. An interest coverage of 0.27 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio18.53%
Debt Equity Ratio5.05
Long Term Debt to Capitalization79.95%
Total Debt to Capitalization83.48%
Interest Coverage0.27
Cash Flow to Debt Ratio-0.38
Company Equity Multiplier27.27

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.08%, indicates top-line expansion, while the gross profit growth, 24.56%, reveals profitability trends. EBIT growth, 57.23%, and operating income growth, 57.23%, offer insights into operational profitability progression. The net income growth, -13.29%, showcases bottom-line expansion, and the EPS growth, 100.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth11.08%
Gross Profit Growth24.56%
EBIT Growth57.23%
Operating Income Growth57.23%
Net Income Growth-13.29%
EPS Growth100.00%
EPS Diluted Growth100.00%
Weighted Average Shares Growth-100.00%
Weighted Average Shares Diluted Growth-100.00%
Operating Cash Flow Growth-639.55%
Free Cash Flow Growth-55.39%
10-Year Revenue Growth per Share-100.00%
5-Year Revenue Growth per Share-100.00%
3-Year Revenue Growth per Share-100.00%
10-Year Operating CF Growth per Share-100.00%
5-Year Operating CF Growth per Share-100.00%
3-Year Operating CF Growth per Share100.00%
10-Year Net Income Growth per Share-100.00%
5-Year Net Income Growth per Share100.00%
3-Year Net Income Growth per Share-100.00%
10-Year Shareholders Equity Growth per Share-100.00%
5-Year Shareholders Equity Growth per Share-100.00%
3-Year Shareholders Equity Growth per Share-100.00%
10-Year Dividend per Share Growth per Share-100.00%
Inventory Growth17.93%
Asset Growth0.18%
Book Value per Share Growth-100.00%
Debt Growth-13.35%
SGA Expenses Growth26.75%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,119,458, captures the company's total value, considering both debt and equity. Income quality, 1.19, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 0.90%, indicates the value of non-physical assets, and capex to operating cash flow, 63.26%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value4,119,458
Income Quality1.19
Sales General and Administrative to Revenue0.29
Intangibles to Total Assets0.90%
Capex to Operating Cash Flow63.26%
Capex to Revenue-5.54%
Capex to Depreciation-123.11%
Return on Tangible Assets-2.85%
Working Capital5,957,805
Tangible Asset Value733,394
Net Current Asset Value-7,074,235
Invested Capital5
Average Payables9,578,647
Average Inventory6,832,825
Days Payables Outstanding432
Days of Inventory On Hand361
ROIC4.03%
ROE-0.77%

Valuation Ratios

The price to sales ratio, 0.40, provides a perspective on valuation in relation to sales.

cards.indicatorcards.value
Price to Sales Ratio0.40
Enterprise Value Multiple2.36
Price to Free Cash Flows Ratio-2.78
Enterprise Value to Sales0.18
Enterprise Value Over EBITDA2.02
EV to Operating Cash Flow-2.10
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medcomtech, S.A. (MED.MC) on the EURONEXT in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 0.000 in 2024.

What is the ticker symbol of Medcomtech, S.A. stock?

The ticker symbol of Medcomtech, S.A. stock is MED.MC.

What is company IPO date?

IPO date of Medcomtech, S.A. is 2010-03-25.

What is company current share price?

Current share price is 0.690 EUR.

What is stock market cap today?

The market cap of stock today is 8915628.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 124.